Stay updated on Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, signaling a subsequent editorial/technical update to the record without changing the underlying study details.
    Difference
    0.1%
    Check dated 2026-06-06T13:40:49.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Adds ovarian cancer as a condition tag and introduces related topics including MedlinePlus Genetics to the study page, improving discoverability and linking to background resources.
    Difference
    0.2%
    Check dated 2026-05-30T12:03:55.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    Ovarian cancer and the related topics: MedlinePlus Genetics have been removed from the page, reducing explicit disease tagging and related topics navigation.
    Difference
    0.2%
    Check dated 2026-05-23T10:22:01.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous v3.5.3, indicating an updated page version.
    Difference
    0.1%
    Check dated 2026-05-15T23:21:28.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    ClinicalTrials.gov updated the page’s displayed revision/version from v3.5.2 to v3.5.3, without any accompanying change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-24T05:52:36.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:31.000Z thumbnail image

Stay in the know with updates to Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.